On the utility of ToxCast™ and ToxPi as methods for identifying new obesogens

Environmental Health Perspectives

Volumn 124, Issue 8, 2016, Pages 1214-1226

  Janesick, Amanda Shaine ^a   Dimastrogiovanni, Giorgio ^b   Vanek, Lenka ^a   Boulos, Christy ^a   Chamorro García, Raquel ^a   Tang, Weiyi ^a   Blumberg, Bruce ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINE DISRUPTOR; OBESOGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; POLLUTANT;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CONTROLLED STUDY; CYTOTOXICITY; EC10; EC50; FLUORESCENCE POLARIZATION; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; IC50; MOUSE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SPECTROFLUOROMETRY; TOXCAST METHOD; TOXICOLOGICAL PARAMETERS; TOXICOLOGICAL PRIORITY INDEX; TRANSIENT TRANSFECTION; ANIMAL; DRUG EFFECTS; HUMAN; PHYSIOLOGY; POLLUTANT; PROCEDURES; TOXICITY; TOXICITY TESTING;

ADIPOGENESIS; ANIMALS; ENVIRONMENTAL POLLUTANTS; HUMANS; MICE; TOXICITY TESTS;

EID: 84980340184     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1510352     Document Type: Article

References (56)

1. Bevington PR, Robinson DK. 2003. Data Reduction and Error Analysis for the Physical Sciences. Boston, MA:McGraw-Hill Education.
2. Browne P, Judson RS, Casey WM, Kleinstreuer NC, Thomas RS. 2015. Screening chemicals for estrogen receptor bioactivity using a computational model. Environ Sci Technol 49(14):8804-8814.
3. Calkin AC, Tontonoz P. 2012. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 13(4):213-224.
4. Chamorro-García R, Blumberg B. 2014. Transgenerational effects of obesogens and the obesity epidemic. Curr Opin Pharmacol 19:153-158.
5. Chamorro-García R, Kirchner S, Li X, Janesick A, Casey SC, Chow C, et al. 2012. Bisphenol A diglycidyl ether induces adipogenic differentiation of multipotent stromal stem cells through a peroxisome proliferator- activated receptor gamma-independent mechanism. Environ Health Perspect 120:984-989, doi:10.1289/ehp.1205063.
6. Chamorro-García R, Sahu M, Abbey RJ, Laude J, Pham N, Blumberg B. 2013. Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. Environ Health Perspect 121:359-366, doi:10.1289/ehp.1205701.
7. Chuprina A, Lukin O, Demoiseaux R, Buzko A, Shivanyuk A. 2010. Drug-and lead-likeness, target class, and molecular diversity analysis of 7.9 million commercially available organic compounds provided by 29 suppliers. J Chem Inf Model 50(4):470-479.
8. Collins FS, Gray GM, Bucher JR. 2008. Toxicology. Transforming environmental health protection. Science 319(5865):906-907.
9. Dahlin JL, Nissink JW, Strasser JM, Francis S, Higgins L, Zhou H, et al. 2015. PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. J Med Chem 58(5):2091-2113.
10. Darlington GJ, Ross SE, MacDougald OA. 1998. The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273(46):30057-30060.
11. Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ. 2007. The ToxCast™ program for prioriti-zing toxicity testing of environmental chemicals. Toxicol Sci 95(1):5-12.
12. Filer D, Patisaul HB, Schug T, Reif D, Thayer K. 2014. Test driving ToxCast: endocrine profiling for 1858 chemicals included in Phase II. Curr Opin Pharmacol 19:145-152.
13. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, et al. 1995. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81(5):687-693.
14. FQPA (Food Quality Protection Act of 1996). 1996. Public Law 104-170.
15. Grün F, Blumberg B. 2006. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147(6 suppl):S50-S55.
16. Grün F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, et al. 2006. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 20(9):2141-2155.
17. Hughes M, Inglese J, Kurtz A, Andalibi A, Patton L, Austin C, et al. 2012. Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies. In: Assay Guidance Manual [Internet] (Sittampalam G, Coussens N, Nelson H, et al., eds). Bethesda, MD: Eli Lilly & Company and the National Center for Advancing Translational Sciences. Available: http://www.ncbi.nlm.nih.gov/books/NBK92015 [accessed 18 May 2015].
18. Hulsen T, de Vlieg J, Alkema W. 2008. BioVenn-a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 9:488, doi:10.1186/1471-2164-9-488.
19. Inglese J, Johnson RL, Simeonov A, Xia M, Zheng W, Austin CP, et al. 2007. High-throughput screening assays for the identification of chemical probes. Nat Chem Biol 3(8):466-479.
20. Jameson DM, Sawyer WH. 1995. Fluorescence aniso-tropy applied to biomolecular interactions. Methods Enzymol 246:283-300.
21. Janesick A, Blumberg B. 2011a. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today 93(1):34-50.
22. Janesick A, Blumberg B. 2011b. Minireview: PPARγ as the target of obesogens. J Steroid Biochem Mol Biol 127(1-2):4-8.
23. Janesick AS, Shioda T, Blumberg B. 2014. Transgenerational inheritance of prenatal obesogen exposure. Mol Cell Endocrinol 398(1-2):31-35.
24. Jolley ME, Stroupe SD, Schwenzer KS, Wang CJ, Lu-Steffes M, Hill HD, et al. 1981. Fluorescence polarization immunoassay. III. An automated system for therapeutic drug determination. Clin Chem 27(9):1575-1579.
25. Kanayama T, Kobayashi N, Mamiya S, Nakanishi T, Nishikawa J. 2005. Organotin compounds promote adipocyte differentiation as agonists of the peroxi-some proliferator-activated receptor γ/retinoid X receptor pathway. Mol Pharmacol 67(3):766-774.
26. Kavlock RJ, Austin CP, Tice RR. 2009. Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal 29(4):485-487.
27. Kavlock R, Chandler K, Houck K, Hunter S, Judson R, Kleinstreuer N, et al. 2012. Update on EPA’s ToxCast™ program: providing high throughput decision support tools for chemical risk manage-ment. Chem Res Toxicol 25(7):1287-1302.
28. Knight AW, Little S, Houck K, Dix D, Judson R, Richard A, et al. 2009. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast™ chemicals. Regul Toxicol Pharmacol 55(2):188-199.
29. Knudsen TB, Houck KA, Sipes NS, Singh AV, Judson RS, Martin MT, et al. 2011. Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets. Toxicology 282(1-2):1-15.
30. Li X, Pham HT, Janesick AS, Blumberg B. 2012. Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARγ). Environ Health Perspect 120:1720-1726, doi:10.1289/ehp.1205383.
31. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402-408.
32. Love JD, Gooch JT, Benko S, Li C, Nagy L, Chatterjee VK, et al. 2002. The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12. J Biol Chem 277(13):11385-11391.
33. Martin MT, Dix DJ, Judson RS, Kavlock RJ, Reif DM, Richard AM, et al. 2010. Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA’s ToxCast™ program. Chem Res Toxicol 23(3):578-590.
34. Masuno H, Kidani T, Sekiya K, Sakayama K, Shiosaka T, Yamamoto H, et al. 2002. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res 43(5):676-684.
35. Muir DC, Howard PH. 2006. Are there other persistent organic pollutants? A challenge for environmental chemists. Environ Sci Technol 40(23):7157-7166.
36. Nakshatri H, Bhat-Nakshatri P. 1998. Multiple param-eters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. Nucleic Acids Res 26(10):2491-2499.
37. Peckett AJ, Wright DC, Riddell MC. 2011. The effects of glucocorticoids on adipose tissue lipid metabo-lism. Metabolism 60(11):1500-1510.
38. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB. 2008. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 19(2):65-73.
39. Reif DM, Martin MT, Tan SW, Houck KA, Judson RS, Richard AM, et al. 2010. Endocrine profiling and prioritization of environmental chemicals using ToxCast™ data. Environ Health Perspect 118:1714-1720, doi:10.1289/ehp.1002180.
40. Reif DM, Sypa M, Lock EF, Wright FA, Wilson A, Cathey T, et al. 2013. ToxPi GUI: an interactive visu-alization tool for transparent integration of data from diverse sources of evidence. Bioinformatics 29(3):402-403.
41. Romanov S, Medvedev A, Gambarian M, Poltoratskaya N, Moeser M, Medvedeva L, et al. 2008. Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors. Nat Methods 5(3):253-260.
42. Rosen ED, MacDougald OA. 2006. Adipocyte differen-tiation from the inside out. Nat Rev Mol Cell Biol 7(12):885-896.
43. Rotroff DM, Dix DJ, Houck KA, Knudsen TB, Martin MT, McLaurin KW, et al. 2013. Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals. Environ Health Perspect 121:7-14, doi:10.1289/ehp.1205065.
44. Rotroff DM, Martin MT, Dix DJ, Filer DL, Houck KA, Knudsen TB, et al. 2014. Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses. Environ Sci Technol 48(15):8706-8716.
45. SDWA Amendments (Safe Drinking Water Act Amendments of 1996). 1996. Public Law 104-182.
46. Silva M, Pham N, Lewis C, Iyer S, Kwok E, Solomon G, et al. 2015. A comparison of ToxCast™ test results with in vivo and other in vitro endpoints for neuro, endocrine, and developmental toxicities: a case study using endosulfan and methidathion. Birth Defects Res B Dev Reprod Toxicol 104(2):71-89.
47. Sweetnam PM, Caldwell L, Lancaster J, Bauer C Jr, McMillan B, Kinnier WJ, et al. 1993. The role of receptor binding in drug discovery. J Nat Prod 56(4):441-455.
48. Temkin AM, Bowers RR, Magaletta ME, Holshouser S, Maggi A, Ciana P, et al. 2016. Effects of crude oil/dispersant mixture and dispersant components on PPARγ activity in vitro and in vivo: identifica-tion of dioctyl sodium sulfosuccinate (DOSS; CAS #577-11-7) as a probable obesogen. Environ Health Perspect 124:112-119, doi:10.1289/ehp.1409672.
49. Thayer KA, Heindel JJ, Bucher JR, Gallo MA. 2012. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ Health Perspect 120:779-789, doi:10.1289/ehp.1104597.
50. Tontonoz P, Spiegelman BM. 2008. Fat and beyond: the diverse biology of PPARγ. Annu Rev Biochem 77:289-312
51. TSCA (Toxic Substances Control Act). 1976. Public Law 94-469.
52. U.S. EPA (U.S. Environmental Protection Agency). 2014a. Integrated Bioactivity and Exposure Ranking: A Computational Approach for Prioritization and Screening of Chemicals in the Endocrine Disruptor Screening Program. Washington, DC:U.S. EPA, Endocrine Disruptor Screening Program. Available: http://www.regulations.gov/contentStreamer?documentId=EPA-HQ-OPP-2014-0614-0003&disposition=attachment&contentType=pdf [accessed 16 March 2015].
53. U.S. EPA. 2014b. TSCA Chemical Substance Inventory Homepage. Available: http://www.epa.gov/oppt/existingchemicals/pubs/tscainventory/basic.html [accessed 16 March 2015].
54. Ubukata M, Takamori H, Ohashi M, Mitsuhashi S, Yamashita K, Asada T, et al. 2007. Mycophenolic acid as a latent agonist of PPARγ. Bioorg Med Chem Lett 17(17):4767-4770.
55. Zlokarnik G, Negulescu PA, Knapp TE, Mere L, Burres N, Feng L, et al. 1998. Quantitation of transcription and clonal selection of single living cells with β-lactamase as reporter. Science 279(5347):84-88.
56. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, et al. 2012. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology 153(9):4097-4110.